Chronic pain affects 20% of the world population. The chronic pain drugs market is currently valued at $62 billion, with opioids leading the revenue contribution at 27%. Opioid analgesics have been the more effective class
Biclonics: A New Era of Immuno-Oncology?
by Jane Antony, PhD | October 15, 2018
Global oncology-related healthcare costs are estimated to surpass $150B by 2021, with an annual growth rate of 6-10%. While conventional therapies (e.g., chemotherapies, small molecule targeted therapies)
Capturing CO2 in your walls
by Christin Schmidt, PhD | October 15, 2018
Pulling carbon dioxide (CO2) from the air to produce synthetic fuels will be the golden bullet in the fight against climate change and against a worldwide shortage of energy resources
Culturing an Expanding Meat Market
by Alan Wang, B.A. | October 2, 2018
For the typical meat lover, a properly prepared steak can be difficult to forego. It’s calorie-rich. It’s satiating. When seared, it generates an unmistakable aroma. It makes mouths water.
Tracking The Tremor: Wearable Technologies in Parkinson’s
by Pallavi Penumetcha, B.S. | January 19, 2018
For 10 million people worldwide, 1 million of whom live in America, everyday tasks are extremely complicated because they live with Parkinson’s Disease (PD). People with PD experience a wide range of motor symptoms
New Solutions For Revitalizing Big Pharma R&D
by Jenny Hsu, Ph.D. | June 18, 2018
Drug research and development (R&D) lies at the heart of the pharma industry and receives a considerable allocation of its resources. Over the last decade, R&D spending across U.S.
FDA Regulation Defines Business Strategy in Direct-to-Consumer Genetic Testing
by Lindsey Jones | October 30, 2017
Why do consumers seek direct-to-consumer (DTC) genetic testing? Consumers purchase services that sequence and analyze portions of their DNA to understand their risk for familial cancer plan a safer pregnancy